Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

AIMS: Finerenone reduces the risk of cardiovascular events in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the FIDELITY population. METHODS AND RESULTS: The FIDELITY prespecified pooled data analysis from FIDELIO-DKD and FIGARO-DKD...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippatos, Gerasimos, Anker, Stefan D, August, Phyllis, Coats, Andrew J S, Januzzi, James L, Mankovsky, Boris, Rossing, Peter, Ruilope, Luis M, Pitt, Bertram, Sarafidis, Pantelis, Teerlink, John R, Kapelios, Chris J, Gebel, Martin, Brinker, Meike, Joseph, Amer, Lage, Andrea, Bakris, George, Agarwal, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892867/
https://www.ncbi.nlm.nih.gov/pubmed/36639130
http://dx.doi.org/10.1093/ehjcvp/pvad001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892867/
https://www.ncbi.nlm.nih.gov/pubmed/36639130
http://dx.doi.org/10.1093/ehjcvp/pvad001

Ejemplares similares